Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Trace Biosciences secures a strategic investment from Axogen in its Series A round to further develop its Nerve Trace imaging technology.

PRIVATEJul 29, 2026•11 days ago

Round Type

Series A

PortlandBiotechnology

Investors

Axogen, Inc.

Description

Trace Biosciences, Inc. announced a strategic investment from Axogen to advance the clinical development of its nerve-specific imaging technology. This investment is part of Trace's Series A financing round, aimed at supporting Phase II and III clinical trials. The funding will enhance the visibility of nerves during surgical procedures, improving surgical outcomes

Company Information

Company

Trace Biosciences

Location

Portland, Oregon, United States

About

Trace Biosciences is a clinical-stage biotechnology company pioneering nerve-targeted imaging technologies for surgery. The company is developing a new class of small-molecule imaging agents designed to make nerves visible and measurable in clinical settings. Its mission is to make safe, precise surgery a reality by making nerves visible in every operating room.

Related People

Suggested for you
3 contacts
Verified contactsConnor, Co-Founder & CEO hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Trace Biosciences's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.